<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05100511</url>
  </required_header>
  <id_info>
    <org_study_id>MACULARERG01</org_study_id>
    <nct_id>NCT05100511</nct_id>
  </id_info>
  <brief_title>Fundus Image-guided Focal Electroretinography, Usability Study</brief_title>
  <official_title>Fundus Image-guided Focal Electroretinography, Usability Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maculaser Oy</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maculaser Oy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the usability of fundus image-guided focal&#xD;
      electroretinography device with healthy subjects and with macular edema and macular&#xD;
      degeneration patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, we will study the usability of focal electroretinography device combined with&#xD;
      slit lamp biomicroscope. The device allows simultaneous fundus imaging and focal ERG&#xD;
      recording from the desired retinal area.&#xD;
&#xD;
      In phase I, the usability of the investigational device is tested with 10 healthy volunteers.&#xD;
      The examinations include focal ERG and noise tests with commercial ERG electrodes. The&#xD;
      stimulus lights are guided to the fundus using either non-contact of contact fundus lens. One&#xD;
      electrode is selected for phase II based on signal-to-noise ration, usability, and comfort.&#xD;
&#xD;
      In phase II, fundus image-guided focal ERG recordings are conducted with total of 10 patients&#xD;
      having either macular edema or macular degeneration. The aim of the phase II is to test&#xD;
      whether the investigational device can be used to record focal ERG signal from the desired&#xD;
      symptomatic retinal area.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 4, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>The usability of the investigational device is examined first with 10 healthy subjects and afterwards with total of 10 patients suffering either from macular edema or macular degeneration.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Signal-to-noise ratio of focal electroretinography signal</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Signal-to-noise ratio of the focal ERG signals with different ERG electrodes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Focal ERG from symptomatic retinal area</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Explore the device feasibility in recording focal ERG signal from areas with macular edema or macular degeneration.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient comfort and usability of different ERG electrodes in focal ERG.</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Investigated using a questionnaire for the subjects and investigator.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Healthy</condition>
  <condition>Macular Edema</condition>
  <condition>Macular Degeneration</condition>
  <arm_group>
    <arm_group_label>Phase I, healthy subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>General usability of the device is tested with healthy patients. Different commercial electroretinography electrodes are tested to investigate the patient comfort, usability and signal-to-noise ratio when recording fundus image-guided focal electroretinography with the investigational device. Most suitable electrode is selected to phase II.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phase II, patients with macular edema or macular degeneration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The usability of the device is tested with patients suffering either from macular edema or macular degeneration. Fundus image-guided focal electroretinography is recorded with the electrode chosen in phase I from two different retinal areas: from an area with macular edema or signs of macular degeneration and from a healthy area (area without macular edema or signs of macular degeneration).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ERG electrode tests for fundus image-guided focal ERG</intervention_name>
    <description>Investigate the patient comfort, usability and signal-to-noise ratio of different commercial CE marked ERG electrodes.</description>
    <arm_group_label>Phase I, healthy subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fundus image-guided focal ERG</intervention_name>
    <description>Record focal ERG from a healthy retinal area and from an area with visible symptoms.</description>
    <arm_group_label>Phase II, patients with macular edema or macular degeneration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy volunteers with no signs of macular edema or macular degeneration (phase I)&#xD;
&#xD;
          -  Patients with either macular edema or macular degeneration (phase II)&#xD;
&#xD;
          -  Able to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Epileptic patients&#xD;
&#xD;
          -  Vulnerable population: pregnant and breastfeeding women, underage, prisoners, persons&#xD;
             with physical handicaps or mental disabilities, and disadvantaged persons.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joni Turunen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Teemu T Turunen, D.Sc.</last_name>
    <phone>+358505544737</phone>
    <email>teemu.turunen@maculaser.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Helsinki University Hospital, Retinal Outpatient Clinic</name>
      <address>
        <city>Helsinki</city>
        <state>Uusimaa</state>
        <zip>00280</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Joni Turunen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 6, 2021</study_first_submitted>
  <study_first_submitted_qc>October 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2021</study_first_posted>
  <last_update_submitted>November 4, 2021</last_update_submitted>
  <last_update_submitted_qc>November 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Electroretinography</keyword>
  <keyword>ERG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Macular Edema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

